Description:

Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02206425

Link:

https://clinicaltrials.gov/show/NCT02206425

Keywords:
Versions (1) ▾
  1. 5/13/19
Copyright Holder:
See clinicaltrials.gov
Uploaded on:

May 13, 2019

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT02206425

Eligibility Multiple Myeloma NCT02206425

Criteria